Physician profile

Patrick M Simon

Orthopaedic Surgery · Live Oak, TX

NPI 1710078969

$2,336.99

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$115.31

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medinc of Texas $2,041.00 2019
Stryker Corporation $59.66 2023 Insignia
Depuy Synthes Sales INC. $54.68 2019
Bioventus LLC $42.68 2019
Ferring Pharmaceuticals INC. $39.37 2019
Think Surgical, INC. $38.79 2024
Sanofi-Aventis U.S. LLC $24.04 2019
Heraeus Medical, LLC. $16.86 2024
Smith+Nephew, INC. $15.35 2021
Orthofix Medical, INC. $4.56 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Patrick M Simon

$2,336.99

in general payments reported 2019-2025

Years
2019-2024
Top company
Medinc of Texas

https://glasscript.com/doctor/168120/patrick-m-simon

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.